DK1687011T3 - Modificerede vacciner baseret på hele celler, celleekstrakter og ydere membranvesikler - Google Patents
Modificerede vacciner baseret på hele celler, celleekstrakter og ydere membranvesiklerInfo
- Publication number
- DK1687011T3 DK1687011T3 DK04768807T DK04768807T DK1687011T3 DK 1687011 T3 DK1687011 T3 DK 1687011T3 DK 04768807 T DK04768807 T DK 04768807T DK 04768807 T DK04768807 T DK 04768807T DK 1687011 T3 DK1687011 T3 DK 1687011T3
- Authority
- DK
- Denmark
- Prior art keywords
- outer membrane
- cell extracts
- whole cells
- vaccines
- membrane vesicles
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 239000000284 extract Substances 0.000 title 1
- 239000012528 membrane Substances 0.000 title 1
- 108010062802 CD66 antigens Proteins 0.000 abstract 2
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 abstract 2
- 241000040340 Oat mosaic virus Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 229940124590 live attenuated vaccine Drugs 0.000 abstract 1
- 229940023012 live-attenuated vaccine Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323709.6A GB0323709D0 (en) | 2003-10-09 | 2003-10-09 | Modified whole cell,cell extract and omv-based vaccines |
| PCT/GB2004/004274 WO2005035733A2 (en) | 2003-10-09 | 2004-10-08 | Modified whole cell, cell extract and omv-based vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1687011T3 true DK1687011T3 (da) | 2008-11-10 |
Family
ID=29433617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04768807T DK1687011T3 (da) | 2003-10-09 | 2004-10-08 | Modificerede vacciner baseret på hele celler, celleekstrakter og ydere membranvesikler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070154495A1 (da) |
| EP (1) | EP1687011B1 (da) |
| JP (1) | JP2007508537A (da) |
| AT (1) | ATE401091T1 (da) |
| AU (1) | AU2004279990B2 (da) |
| CA (1) | CA2541834C (da) |
| DE (1) | DE602004015141D1 (da) |
| DK (1) | DK1687011T3 (da) |
| ES (1) | ES2310753T3 (da) |
| GB (1) | GB0323709D0 (da) |
| PT (1) | PT1687011E (da) |
| WO (1) | WO2005035733A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011027956A2 (ko) | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
| US9201072B2 (en) | 2009-09-01 | 2015-12-01 | Aeon Medix Inc. | Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same |
| WO2011043538A2 (ko) * | 2009-10-08 | 2011-04-14 | 주식회사이언메딕스 | 실내 공기유래 세포밖 소포체를 포함하는 조성물 및 이의 용도 |
| JP2011169834A (ja) * | 2010-02-19 | 2011-09-01 | Kansai Bunri Sogo Gakuen | 病原性グラム陰性細菌由来脂質小胞の検出方法および検出システム |
| KR20160101521A (ko) * | 2015-02-17 | 2016-08-25 | 이화여자대학교 산학협력단 | 세균 유래 세포밖 소포체를 이용한 호흡기 염증성 질환의 진단방법 |
| EP3506933A2 (en) * | 2016-09-02 | 2019-07-10 | GlaxoSmithKline Biologicals SA | Vaccines for neisseria gonorrhoeae |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
| GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
| NZ587398A (en) * | 2002-08-02 | 2012-03-30 | Glaxosmithkline Biolog Sa | Neisserial bleb preparations and vaccines comprising them |
-
2003
- 2003-10-09 GB GBGB0323709.6A patent/GB0323709D0/en not_active Ceased
-
2004
- 2004-10-08 ES ES04768807T patent/ES2310753T3/es not_active Expired - Lifetime
- 2004-10-08 DK DK04768807T patent/DK1687011T3/da active
- 2004-10-08 DE DE602004015141T patent/DE602004015141D1/de not_active Expired - Lifetime
- 2004-10-08 WO PCT/GB2004/004274 patent/WO2005035733A2/en not_active Ceased
- 2004-10-08 JP JP2006530598A patent/JP2007508537A/ja active Pending
- 2004-10-08 AU AU2004279990A patent/AU2004279990B2/en not_active Ceased
- 2004-10-08 US US10/575,070 patent/US20070154495A1/en not_active Abandoned
- 2004-10-08 EP EP04768807A patent/EP1687011B1/en not_active Expired - Lifetime
- 2004-10-08 PT PT04768807T patent/PT1687011E/pt unknown
- 2004-10-08 AT AT04768807T patent/ATE401091T1/de active
- 2004-10-08 CA CA2541834A patent/CA2541834C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1687011B1 (en) | 2008-07-16 |
| EP1687011A2 (en) | 2006-08-09 |
| US20070154495A1 (en) | 2007-07-05 |
| DE602004015141D1 (de) | 2008-08-28 |
| ATE401091T1 (de) | 2008-08-15 |
| WO2005035733A2 (en) | 2005-04-21 |
| AU2004279990A1 (en) | 2005-04-21 |
| WO2005035733A3 (en) | 2005-12-29 |
| GB0323709D0 (en) | 2003-11-12 |
| ES2310753T3 (es) | 2009-01-16 |
| CA2541834C (en) | 2012-09-04 |
| AU2004279990B2 (en) | 2010-04-01 |
| CA2541834A1 (en) | 2005-04-21 |
| JP2007508537A (ja) | 2007-04-05 |
| PT1687011E (pt) | 2008-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60043708D1 (de) | Verfahren zur erhaltung zellimmuneantworten gegen proteinen | |
| CR7875A (es) | Variantes de inmunoglobina y usos de esto | |
| NO20023829L (no) | Proteosom influensavaksine | |
| BRPI0507169A (pt) | polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos | |
| DK1513937T3 (da) | Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved | |
| NO20030856D0 (no) | Membranpenetrerende peptider og anvendelse av disse | |
| SI1644484T1 (sl) | Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah | |
| BR9811475A (pt) | Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae | |
| DK1626979T3 (da) | Genetisk modificeret gærart og fremgangsmåder til fermentering, hvor den genetisk modificerede gær anvendes | |
| PL1957539T3 (pl) | Ludzkie przeciwciała monoklonalne przeciwko białku kinazy tyrozynowej 7 (PTK7) i ich zastosowanie | |
| EA199800946A1 (ru) | Концентрированный препарат антител | |
| ATE517340T1 (de) | Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren | |
| SG160424A1 (en) | Compositions of influenza viral proteins and methods of use thereof | |
| ATE460176T1 (de) | Mikrosomvakzin | |
| CU20210041A7 (es) | Péptidos inmunogénicos con motivos de oxidorreductasa | |
| DK1687011T3 (da) | Modificerede vacciner baseret på hele celler, celleekstrakter og ydere membranvesikler | |
| ATE473236T1 (de) | Antigene von piscirickettsia salmonis und deren verwendung | |
| WO2007016185A3 (en) | Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination | |
| TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
| EA200970731A1 (ru) | Рекомбинантные антигены цитомегаловируса человека (hcmv) | |
| DK1290160T3 (da) | Humane Pellino-polypeptider | |
| NO20024223D0 (no) | Monoklane antistoffer til den humane LDL-reseptor, deres fremstilling og anvendelse | |
| ATE389397T1 (de) | Adjuvante zusammensetzungen | |
| EP2193804A3 (en) | Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens | |
| ATE385809T1 (de) | Saponin-zusammensetzungen und deren verwendung |